Ajax Therapeutics logo

Ajax Therapeutics Funding & Investors

New York, NY

Ajax is targeting hematologic malignancies with greater precision by applying state-of-the-art computational chemistry and structural biology throughout the drug discovery and development process to create best-in-class therapies for significant unmet medical needs.

ajaxtherapeutics.com

Total Amount Raised: $143,000,000

Ajax Therapeutics Funding Rounds

  • Series C

    $95,000,000

    Series C Investors

    Goldman Sachs Asset Management
    Schrodinger
    Point72 Ventures
    Eli Lilly
    Inning One Ventures
    Boxer Capital
    Ra Capital Management
    Vivo Capital
    EcoR1 Capital
  • Series Unknown

    $40,000,000

    Series Unknown Investors

    EcoR1 Capital
    Memorial Sloan Kettering Cancer Center
    Boxer Capital
    Inning One Ventures
    Schrodinger
    NYU Langone Health
  • Series Unknown

    $8,000,000

Funding info provided by Diffbot.